Craig A Tooman - Net Worth and Insider Trading
Craig A Tooman Net Worth
The estimated net worth of Craig A Tooman is at least $381,631 dollars as of 2024-04-25. Craig A Tooman is the CHIEF FINANCIAL OFFICER of Aratana Therapeutics Inc and owns about 75,024 shares of Aratana Therapeutics Inc (PETX) stock worth over $369,118. Craig A Tooman is also the Exec VP Finance, CFO of Enzon Pharmaceuticals Inc and owns about 160,480 shares of Enzon Pharmaceuticals Inc (ENZN) stock worth over $12,513. Details can be seen in Craig A Tooman's Latest Holdings Summary section.
Disclaimer: The insider information is derived from SEC filings. The estimated net worth is based on the assumption that Craig A Tooman has not made any transactions after 2018-01-11 and currently still holds the listed stock(s).
Transaction Summary of Craig A Tooman
Craig A Tooman Insider Ownership Reports
Based on ownership reports from SEC filings, as the reporting owner, Craig A Tooman owns 3 companies in total, including Aratana Therapeutics Inc (PETX) , InSite Vision Inc (INSV) , and Enzon Pharmaceuticals Inc (ENZN) .
Click here to see the complete history of Craig A Tooman’s form 4 insider trades.
Insider Ownership Summary of Craig A Tooman
| Ticker | Comapny | Transaction Date | Type of Owner |
|---|---|---|---|
| PETX | Aratana Therapeutics Inc | 2019-07-18 | director & President and CEO |
| INSV | InSite Vision Inc | 2015-11-02 | director |
| ENZN | Enzon Pharmaceuticals Inc | 2010-06-18 | Exec VP Finance & CFO |
Craig A Tooman Latest Holdings Summary
Craig A Tooman currently owns a total of 2 stocks. Among these stocks, Craig A Tooman owns 75,024 shares of Aratana Therapeutics Inc (PETX) as of January 11, 2018, with a value of $369,118 and a weighting of 96.72%. Craig A Tooman also owns 160,480 shares of Enzon Pharmaceuticals Inc (ENZN) as of June 18, 2010, with a value of $12,513 and a weighting of 3.28%.
Latest Holdings of Craig A Tooman
| Ticker | Comapny | Latest Transaction Date | Shares Owned | Current Price ($) | Current Value ($) |
|---|---|---|---|---|---|
| PETX | Aratana Therapeutics Inc | 2018-01-11 | 75,024 | 4.92 | 369,118 |
| ENZN | Enzon Pharmaceuticals Inc | 2010-06-18 | 160,480 | 0.08 | 12,513 |
Holding Weightings of Craig A Tooman
Craig A Tooman Form 4 Trading Tracker
According to the SEC Form 4 filings, Craig A Tooman has made a total of 0 transactions in Aratana Therapeutics Inc (PETX) over the past 5 years. The most-recent trade in Aratana Therapeutics Inc is the sale of 30,000 shares on January 11, 2018, which brought Craig A Tooman around $158,100.
According to the SEC Form 4 filings, Craig A Tooman has made a total of 0 transactions in Enzon Pharmaceuticals Inc (ENZN) over the past 5 years. The most-recent trade in Enzon Pharmaceuticals Inc is the sale of 123,100 shares on June 18, 2010, which brought Craig A Tooman around $1 Million.
Insider Trading History of Craig A Tooman
- 1
Craig A Tooman Trading Performance
GuruFocus tracks the stock performance after each of Craig A Tooman's buying transactions within different timeframes. To be detailed, the average return of stocks after 3 months bought by Craig A Tooman is -6.15%. GuruFocus also compares Craig A Tooman's trading performance to market benchmark return within the same time period. The performance of stocks bought by Craig A Tooman within 3 months outperforms 1 times out of 2 transactions in total compared to the return of S&P 500 within the same period.
You can select different timeframes to see how Craig A Tooman's insider trading performs compared to the benchmark.
Performance of Craig A Tooman
Average Return
17.15%
Outperforming Transactions
100%
| 1 Month | 3 Months | 6 Months | 1 Year | 2 Years | 3 Years | |
|---|---|---|---|---|---|---|
| Return(%) | 10.67 | -6.15 | 18.67 | 17.15 | -0.77 | -0.1 |
| Relative Return to S&P 500(%) | 9.79 | -3.64 | 19.69 | 16.5 | 10.03 | 13.51 |
Craig A Tooman Ownership Network
Ownership Network List of Craig A Tooman
Ownership Network Relation of Craig A Tooman
Craig A Tooman Owned Company Details
What does Aratana Therapeutics Inc do?
Who are the key executives at Aratana Therapeutics Inc?
Craig A Tooman is the director & President and CEO of Aratana Therapeutics Inc. Other key executives at Aratana Therapeutics Inc include 10 percent owner Broadfin Healthcare Master Fund Ltd , 10 percent owner Broadfin Capital, Llc , and 10 percent owner Kevin Kotler .
Aratana Therapeutics Inc (PETX) Insider Trades Summary
In summary, during the past 3 months, insiders sold 0 shares of Aratana Therapeutics Inc (PETX) in total and bought 0 shares, with a net sale of 0 shares. During the past 18 months, 0 shares of Aratana Therapeutics Inc (PETX) were sold and 0 shares were bought by its insiders, resulting in a net sale of 0 shares.
Aratana Therapeutics Inc (PETX)'s detailed insider trading history can be found in Insider Trading Tracker table.
Aratana Therapeutics Inc Insider Transactions
Craig A Tooman Mailing Address
Above is the net worth, insider trading, and ownership report for Craig A Tooman. Currently GuruFocus does not have mailing address information for Craig A Tooman.
We'd love to learn more about your experiences on GuruFocus.com and how we can improve!
Take Survey
